Evidence map›Paper›PMID 32885091›Full record

ArticleContemporary clinical trials communications2020

The MEDGICarb-Study: Design of a multi-center randomized controlled trial to determine the differential health-promoting effects of low- and high-glycemic index Mediterranean-style eating patterns.

Robert E Bergia, Izabela Biskup, Rosalba Giacco, Giuseppina Costabile, Savanna Gray, Amy Wright, Marilena Vitale, Wayne W Campbell, Rikard Landberg, Gabriele Riccardi

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Robert E BergiaDepartment of Nutrition Science, Purdue University, 700 West State St, West Lafayette, IN, 47907, USA.
Izabela BiskupDepartment of Biology and Biological Engineering, Food Science and Nutrition, Chalmers University of Technology, Gothenburg, Sweden.
Rosalba GiaccoDiabetes, Nutrition and Metabolism Unit, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Giuseppina CostabileDiabetes, Nutrition and Metabolism Unit, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Savanna GrayDepartment of Nutrition Science, Purdue University, 700 West State St, West Lafayette, IN, 47907, USA.
Amy WrightDepartment of Nutrition Science, Purdue University, 700 West State St, West Lafayette, IN, 47907, USA.
Marilena VitaleDiabetes, Nutrition and Metabolism Unit, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Wayne W CampbellDepartment of Nutrition Science, Purdue University, 700 West State St, West Lafayette, IN, 47907, USA.
Rikard LandbergDepartment of Biology and Biological Engineering, Food Science and Nutrition, Chalmers University of Technology, Gothenburg, Sweden.
Gabriele RiccardiInstitute of Food Science, National Research Council, Avellino, Italy.
Purdue University West Lafayette · USChalmers University of Technology · SEFederico II University Hospital · ITInstitute of Food Science · IT

Funding

Predicting Health Outcomes of Mediterranean Diet via Metabolomics of Foods and BiospecimensR01DK113957 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, WAYNE W, KREBS, NANCY F · 2018 to 2022
$3.2M
NIDDK NIH HHS R01 DK113957
6 · The paper itself

Abstract

Adults with central adiposity and other features of the metabolic syndrome have a markedly elevated risk of developing type 2 diabetes (T2D) and cardiovascular disease (CVD). A Mediterranean-style healthy eating pattern (MED-HEP) and consumption of foods with a lower glycemic index (GI) are potential dietary approaches to curb the T2D and CVD epidemic. However, experimental evidence of the effectiveness of MED-HEP and of the contribution of GI towards improving indices of glucose homeostasis, especially among non-diabetic people, are lacking. Therefore, we developed the MedGI-Carb trial, a multi-center (Italy, Sweden, and United States) intervention in adults with at least two components of the metabolic syndrome (elevated waist circumference + one other component) that aims to improve markers of glucose homeostasis through dietary modification. All participants were randomized to consume an isocaloric high- or low-GI MED-HEP for 12 weeks. We hypothesized that indexes of insulinemia (primary outcome: postprandial insulin and glucose after standardized breakfast and lunch; secondary outcomes: fasting plasma glucose and insulin, HbA

Indexed as

Cardiometabolic healthGlucose controlGlycaemiaInsulinemiaMediterranean diet

Identifiers

PMID32885091
PMCPMC7451809
OpenAlexW3049496027

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.